The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Presynaptic nicotinic receptors modulating dopamine release in the rat striatum
Abstract
The modulation of striatal dopamine release by presynaptic nicotinic acetylcholine receptors is well documented for both synaptosomes and slices. Because the latter retain local anatomical integrity, we have compared [3H]dopamine release evoked by the nicotinic receptor agonists (-)-nicotine and (+/-)-anatoxin-a from striatal synaptosome and slice preparations in parallel. At higher agonist concentrations, mecamylamine-sensitive [3H]dopamine release was greater from slices, indicative of an additional component, and this increase was abolished by glutamate receptor antagonists. To begin to examine the localisation of specific nicotinic acetylcholine receptor subtypes in the striatum, immunogold electron microscopy was undertaken with the beta2-specific monoclonal antibody 270. In striatal sections, gold particles were associated with symmetric synapses (dopaminergic) but were absent from asymmetric synapses (glutamatergic). Surface labelling of striatal synaptosomes with gold particles was also demonstrated. Taken together, these results are consistent with dopamine release mediated by beta2-containing nicotinic acetylcholine receptors on dopamine terminals, while non-beta2-containing nicotinic acetylcholine receptors may enhance dopamine release indirectly by releasing glutamate from neighbouring terminals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, nicotine has a cascading effect on central neurotransmission also resulting in the release of norepinephrine and histamine as well as GABA and glutamate (28, 29).”
From The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review (2023) · cites this paper as [29]
Citations
Cites
THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY
Reynolds, E. S. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.1.208 · Cited by 24,938
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Self-citationNicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
Smith, A. D., & Bolam, J. P. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90106-k · Cited by 1,040
Hippocampal synaptic transmission enhanced by low concentrations of nicotine
Gray, R. G. F., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996) · Nature · doi:10.1038/383713a0 · Cited by 947
Baude, A., Nusser, Z., Roberts, J. D. B., Mulvihill, E., Jeffrey Mcllhinney, R. A., & Somogyi, P. (1993) · Neuron · doi:10.1016/0896-6273(93)90086-7 · Cited by 927
Nicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762
A simple apparatus for studying the release of neurotransmitters from synaptosomes
Raiteri, M., Angelini, F., & Levi, G. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90272-6 · Cited by 459
Dunkley, P. R., Heath, J. W., Harrison, S. M., Jarvie, P. E., Glenfield, P. J., & Rostas, J. A. P. (1988) · Brain Research · doi:10.1016/0006-8993(88)91383-2 · Cited by 365
Research works printed but not linked: 2
- Grady, 1998, Nicotine stimulated synaptosomal neurotransmitter release from beta-2 null mutant mice, Soc. Neurosci. Abstr., 24, 1342
- Kaiser, 1998, Nicotinic receptor modulation of neurotransmitter release, Vol. 8, 141
Cited by
Sorted by citations
Items 101–200 of 234
Section I. The Cholinergic System
Smythies, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)64001-9 · Cited by 32
Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine
Janhunen, S. K., & Ahtee, L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.015 · Cited by 32
Hanada, Y., Kawahara, Y., Ohnishi, Y. N., Shuto, T., Kuroiwa, M., Sotogaku, N., Greengard, P., Sagi, Y., & Nishi, A. (2018) · eNeuro · doi:10.1523/eneuro.0332-18.2018 · Cited by 30
Yang, Z., Seneviratne, C., Wang, S., Ma, J. Z., Payne, T. J., Wang, J., & Li, M. D. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.12.007 · Cited by 31
Morgenstern, N. A., Isidro, A. F., Israely, I., & Costa, R. M. (2022) · Science Advances · doi:10.1126/sciadv.abh4315 · Cited by 30
Pratt, W. E., Spencer, R. C., & Kelley, A. E. (2007) · Behavioral Neuroscience · doi:10.1037/0735-7044.121.6.1215 · Cited by 29
Abin‐Carriquiry, J. A., Costa, G., Urbanavicius, J., Cassels, B. K., Rebolledo-Fuentes, M., Wonnacott, S., & Dajas, F. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.013 · Cited by 29
Self-citationChen, R., Ferris, M. J., & Wang, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107583 · Cited by 30
Smoking‐responsive juvenile‐onset Parkinsonism
Hanagasi, H. A., Lees, A. J., Johnson, J. O., Singleton, A., & Emre, M. (2006) · Movement Disorders · doi:10.1002/mds.21177 · Cited by 26
Neuronal Nicotinic Acetylcholine Receptors and Epilepsy
Bertrand, D. (2002) · Epiliepsy currents/Epilepsy currents · doi:10.1046/j.1535-7597.2002.00072.x · Cited by 25
Histamine H1 antagonist treatment with pyrilamine reduces nicotine self-administration in rats
Levin, E. D., Slade, S. K., Wells, C., Pruitt, M., Cousins, V., Cauley, M. C., Petro, A. E., Hampton, D., & Rose, J. E. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.013 · Cited by 25
In vivo Effects of the Anatoxin-a on Striatal Dopamine Release
Campos, F., Durán, R., Vidal, L., Faro, L. R. F., & Alfonso, M. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9042-x · Cited by 25
Henderson, Z., Boros, A. M., Janzsó, G., Westwood, A. J., Monyer, H., & Halasy, K. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.070300 · Cited by 25
Grinevich, V. P., Crooks, P. A., Sumithran, S. P., Haubner, A. J., Ayers, J. T., & Dwoskin, L. P. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051789 · Cited by 25
Nayak, S. V., Dougherty, J. J., McIntosh, J. M., & Nichols, R. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00197.x · Cited by 25
Northrop, N. A., Smith, L. P., Yamamoto, B. K., & Eyerman, D. J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.177287 · Cited by 24
The striatal cholinergic system in l-dopa-induced dyskinesias
Perez, X. A., Bordia, T., & Quik, M. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1845-9 · Cited by 25
Dong, Y., Zhang, T., Li, W., Doyon, W., & Dani, J. A. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9231-6 · Cited by 23
Bordia, T., McIntosh, J. M., & Quik, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12179 · Cited by 23
Riegert, C., Wedekind, F., Hamida, S. B., Rutz, S., Rothmaier, A. K., Jones, B. C., Cassel, J., & Jackisch, R. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008481 · Cited by 22
Recent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism
Rahman, S., Engleman, E. A., & Bell, R. L. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.004 · Cited by 28
Liu, Z., Otsu, Y., Vasuta, C., Nawa, H., & Murphy, T. H. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00768.2006 · Cited by 23
Windels, F., & Kiyatkin, E. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02492.x · Cited by 23
Sorger, D., Becker, G., Patt, M., Schildan, A., Großmann, U., Schliebs, R., Seese, A., Kendziorra, K., Kluge, M., Brust, P., et al. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.12.008 · Cited by 22
Grinevich, V. P., Zakirov, A. N., Berseneva, U. V., Gerasimova, E., Gainetdinov, R. R., & Budygin, E. A. (2022) · Cells · doi:10.3390/cells11091533 · Cited by 21
Efange, S. M. N., Tu, Z., von Hohenberg, K., Francesconi, L. C., Howell, R. C., Rampersad, M. V., TODARO, L. J., Papke, R. L., & Kung, M. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010129z · Cited by 21
Leyrer‐Jackson, J. M., Holter, M. C., Overby, P. F., Newbern, J. M., Scofield, M. D., Olive, M. F., & Gipson, C. D. (2020) · eNeuro · doi:10.1523/eneuro.0276-20.2020 · Cited by 20
Weruaga, E., Balkan, B., Koylu, E. O., Pöğün, Ş., & Alonso, J. R. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10158 · Cited by 20
Global actions of nicotine on the striatal microcircuit
Plata, V. T. G., Duhne, M., Pérez-Ortega, J., Hernandez-Martinez, R., Rueda‐Orozco, P. E., Galarraga, E., Drucker-Colı́n, R., & Bargas, J. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00078 · Cited by 19
Campos, F., Alfonso, M., Vidal, L., Faro, L. R. F., & Durán, R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.044 · Cited by 19
Synaptic Plasticity Within Midbrain Dopamine Centers Contributes to Nicotine Addiction
Placzek, A. N., & Dani, J. A. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_2 · Cited by 18
Adermark, L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.039 · Cited by 19
Mancini, M., Patel, J. C., Affinati, A. H., Witkovsky, P., & Rice, M. E. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0238-22.2022 · Cited by 18
Garção, P., Oliveira, C. R., Cunha, R. A., & Agostinho, P. M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.02.018 · Cited by 17
Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach
Völter, C. J., Riedel, M. J., Wöstmann, N. M., Aichert, D. S., Lobo, S. E. M., Costa, A. C. L., Schmechtig, A., Collier, D. A., Hartmann, A. M., Giegling, I., et al. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001787 · Cited by 17
Janhunen, S. K., Mielikäinen, P., Paldánius, P. M., Tuominen, R. K., Ahtee, L., & Kaakkola, S. (2005) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-005-1066-2 · Cited by 16
Methadone’s effect on nAChRs—a link between methadone use and smoking?
Talka, R., Tuominen, R. K., & Salminen, O. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.031 · Cited by 15
Effect of the 5-HT6 serotonin antagonist MS-245 on the actions of (−)nicotine
Young, R. C., Bondareva, T. S., Wesołowska, A., YOUNG, S., & Glennon, R. A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.029 · Cited by 15
Janhunen, S. K., Tuominen, R. K., Piepponen, P. T., & Ahtee, L. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.017 · Cited by 15
Mechanism of nicotine‐evoked release of [3H]‐noradrenaline in human cerebral cortex slices
Woo, R., Park, E., Shin, M., Jeong, M.-S., Zhao, R., Shin, B., Kim, C., Park, J., & Kim, K.-W. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704975 · Cited by 14
Nicotinic acetylcholine receptors on NT2 precursor cells and hNT (NT2-N) neurons
Newman, M. B., Kuo, Y.-P., Lukas, R. J., Sanberg, P. R., Shytle, R. D., McGrogan, M. P., & Zigova, T. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00513-8 · Cited by 14
Han, H., Liu, Q., Yang, Z., Wang, M., Ma, Y., Cao, L., Cui, W., Yuan, W., Payne, T. J., Li, L., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0290-8 · Cited by 13
Nicotine and methamphetamine disrupt habituation of sensory reinforcer effectiveness in male rats.
Lloyd, D. R., Hausknecht, K. A., & Richards, J. B. (2014) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0034741 · Cited by 14
Matera, C., Pucci, L., Fiorentini, C., Fucile, S., Missale, C., Grazioso, G., Clementi, F., Zoli, M., Amici, M. D., Gotti, C., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.039 · Cited by 13
Studies of muscarinic neurotransmission with antimuscarinic toxins
Potter, L. T., Flynn, D. D., Liang, J., & McCollum, M. H. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45008-5 · Cited by 13
Motor deficits and altered striatal gene expression in aphakia (ak) mice
Singh, B., Wilson, J. H., Vasavada, H. H., Guo, Z., Allore, H. G., & Zeiss, C. J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.006 · Cited by 13
Bednar, I., Friberg, L., & Nordberg, A. K. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.05.004 · Cited by 13
Turchi, J. N., Buffalari, D. M., & Mishkin, M. (2008) · Learning & Memory · doi:10.1101/lm.966208 · Cited by 13
Nucleus accumbens microcircuit underlying D2-MSN-driven increase in motivation
Cunha, C. (2018) · doi:10.26226/morressier.5b31ec342afeeb001345b5c8 · Cited by 13
Extrinsic and intrinsic control of striatal cholinergic interneuron activity
Ratna, D., & Francis, T. C. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1528419 · Cited by 13
Forró, E., Kiss, L., Árva, J., & Fülöp, F. (2017) · Molecules · doi:10.3390/molecules22122211 · Cited by 12
Jung, Y. J., Choi, H., & Oh, E. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136265 · Cited by 12
Dwoskin, L. P., Pivavarchyk, M., Joyce, B. M., Neugebauer, N. M., Zheng, G., Zhang, Z., Bardo, M. T., & Crooks, P. A. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_4 · Cited by 12
Riley, H. H., Zalud, A. W., & Diaz‐Granados, J. L. (2010) · Alcohol · doi:10.1016/j.alcohol.2009.10.013 · Cited by 11
Double target concept for smoking cessation
Wu, J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.137 · Cited by 11
Paraquat Exposure Reduces Nicotinic Receptor-Evoked Dopamine Release in Monkey Striatum
O’Leary, K. T., Parameswaran, N., Johnston, L. C., McIntosh, J. M., Monte, D. A. D., & Quik, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141861 · Cited by 11
Cyanobacterial (blue-green algae) toxins
Puschner, B., & Roegner, A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385926-6.00083-1 · Cited by 10
Collo, G., Cavalleri, L., Zoli, M., Maskos, U., Ratti, E., & Pich, E. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00572 · Cited by 10
The modulation of striatal dopamine release correlates with water-maze performance in aged rats
Rutz, S., Majchrzak, M. J., Siedschlag, V., Barbelivien, A., Harati, H., Rothmaier, A. K., Feuerstein, T. J., Jackisch, R., & Cassel, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.09.011 · Cited by 11
Regulation of Extracellular Dopamine: Release and Uptake
Sulzer, D., Cragg, S. J., & Rice, M. E. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00019-2 · Cited by 10
Grunze, A., Mosolov, S., Grunze, H., & Born, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1114432 · Cited by 11
“In addition, nicotine has a cascading effect on central neurotransmission also resulting in the release of norepinephrine and histamine as well as GABA and glutamate (28, 29).”
BackgroundSwenson, S. M., Hill, S. P., Adeshina, D., Hammers, G. V., McSweeney, S. M., Sword, M. K., Grooms, M. O., Maddox, S. K., Strcula, H. D., Olszewski, N. A., et al. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103651 · Cited by 12
Papke, R. L. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.08.001 · Cited by 9
Cyanobacterial (blue-green algae) toxins
Puschner, B., & Humbert, J. F. (2007) · Elsevier eBooks · doi:10.1016/b978-012370467-2/50156-5 · Cited by 9
In vivo neurochemical characterization of Anatoxin-a evoked dopamine release from striatum
Campos, F., Durán, R., Vidal, L., Faro, L. R. F., & Alfonso, M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0542-2 · Cited by 9
Mann, T., Zilles, K., Klawitter, F., Cremer, M., Hawlitschka, A., Palomero‐Gallagher, N., Schmitt, O., & Wree, A. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00065 · Cited by 8
c‐Fos marking of identified midbrain neurons coactive after nicotine administration in‐vivo
Baur, K., Hach, A., Bernardi, R. E., Spanagel, R., Bading, H., & Bengtson, C. P. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24471 · Cited by 9
Vural, İ. M., Fincan, G. S. Ö., Bozkurt, N. B., Ercan, Z. S., & Sarıoğlu, Y. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.11.032 · Cited by 7
George, A. K., Kaimal, S. B., & Paulose, C. S. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9498-2 · Cited by 7
Fartootzadeh, R., Azizi, F., Alaei, H., & Reisi, P. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.12.013 · Cited by 7
Genetic susceptibility to nicotine and/or alcohol addiction: a systematic review
Legáz, I., Pérez-Cárceles, M. D., de la Calle, I., Arjona, F., Roca, M., Cejudo, P., Maldonado, A. L., & Osuna, E. (2019) · Toxin Reviews · doi:10.1080/15569543.2019.1619085 · Cited by 7
Pakkanen, J. S., Stenfors, J., Jokitalo, E., & Tuominen, R. K. (2006) · Synapse · doi:10.1002/syn.20249 · Cited by 7
Effects of Nicotine on Dopaminergic Neurotransmission
Rowell, P. P. (2001) · Frontiers in neuroscience · doi:10.1201/9781420038521.ch3 · Cited by 7
Gu, Q., Liu, X., Zeng, Q., Guan, X., Zhou, C., Guo, T., Zhang, B., & Zhang, M. (2022) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-21-1090 · Cited by 6
Chronic nicotine impairs sparse motor learning via striatal fast‐spiking parvalbumin interneurons
Kim, B. S., & Im, H. (2020) · Addiction Biology · doi:10.1111/adb.12956 · Cited by 8
Roman, S. A., Badı́a, A., Camps, P., Muñoz‐Torrero, D., & Clos, M. V. (2005) · Brain Research · doi:10.1016/j.brainres.2005.07.042 · Cited by 6
Human Disorders Caused by the Disruption of the Regulation of Excitatory Neurotransmission
Steinlein, O. K. (2007) · Springer eBooks · doi:10.1007/400_2007_034 · Cited by 6
Regulation of Extracellular Dopamine
Sulzer, D., Zhang, H., Benoit‐Marand, M., & Gonon, F. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00017-2 · Cited by 8
Costas-Ferreira, C., Durán, R., & Faro, L. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4651 · Cited by 3
Toyoda, H. (2019) · Synapse · doi:10.1002/syn.22094 · Cited by 5
Randall, P. A., Sun, D., & Randall, P. A. (2024) · Alcohol · doi:10.1016/j.alcohol.2024.08.003 · Cited by 4
Pyrilamine inhibits nicotine-induced catecholamine secretion
Kim, D., Yun, S. J., Park, Y., Jun, D., Kim, D., Singh, N. J., Kim, S., & Kim, K. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.04.015 · Cited by 4
Baladi, M. G., Nielsen, S. M., McIntosh, J. M., Hanson, G. R., & Fleckenstein, A. E. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000215 · Cited by 4
Presynaptic Nicotinic Acetylcholine Receptors and the Modulation of Circuit Excitability
Zhong, C., López‐Hernández, G. Y., Talmage, D. A., & Role, L. W. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_7 · Cited by 4
Presynaptic nicotinic acetylcholine receptors: subtypes mediating neurotransmitter release
Wonnacott, S., Mogg, A. J., Bradly, A. L., & Jones, I. W. (2001) · Cited by 4
Self-citationMonoamine Transporters in Drugs of Abuse: Insights from Fast Scan Cyclic Voltammetry
Samels, S. B., Yüksel, P., & España, R. A. (2025) · Advances in neurobiology · doi:10.1007/978-3-031-96364-3_7 · Cited by 3
Mechanisms Underlying Dopaminergic Regulation of Nicotine-Induced Kinetic Tremor
Kato, M., Kunisawa, N., Shimizu, S., Iha, H. A., & Ohno, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.938175 · Cited by 4
Transdermal Drug Delivery in Parkinson’s Disease
Pfeiffer, R. F. (2007) · Aging Health · doi:10.2217/1745509x.3.4.471 · Cited by 3
Dose-dependent effects of adenosine antagonists on tacrine-induced tremulous jaw movements
Johnson, J. A., Montgomery, A. P., Starr, E. R., Ludwig, J., & Trevitt, J. T. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.004 · Cited by 3
Bioactive compounds and pigments from cyanobacteria: Applications in the pharmaceutical industry
Sitther, V., Wyatt, L., Jones, C., & Yalcin, Y. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91202-0.00009-9 · Cited by 3
Rapidly emerging adolescent nicotine-induced dendritic remodeling is D1-dopamine receptor dependent
Ehlinger, D. G. (2014) · doi:10.13021/mars/5259 · Cited by 3
Huang, X., Xu, Y. J., Li, Q., Liu, P., Yang, Y., Zhang, F., Guo, T., Yang, C., & Guo, L. (2009) · Tsinghua Science & Technology · doi:10.1016/s1007-0214(09)70113-0 · Cited by 2
del Pilar, E. (2012) · Cited by 2
Neurochemistry of Nicotine Dependence
Brunzell, D. H. (2007) · CRC Press eBooks · doi:10.1201/9781420054422.ch2 · Cited by 2
Pharmacology of Drugs of Abuse: Pharmacokinetics and Pharmacodynamics of Psychotropic Compounds
Guimarães, M. Z. P., & Neves, G. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-62855-0_8 · Cited by 3
Tajima, T., Hatano, K., Suzuki, M., Ogawa, M., Sakiyama, Y., Kato, T., Endo, H., Miura, H., Matsubara, M., & Ito, K. (2007) · Synapse · doi:10.1002/syn.20447 · Cited by 2
Cholinergic Interneurons as a Novel Target of CRF in the Striatum that is Spared by Repeated StressPreprint
Lemos, J. C., Shin, J. H., Ingebretson, A. E., Dobbs, L. K., & Alvarez, V. A. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3280248 · Cited by 2
Pyramidal tract neurons drive feed-forward excitation of striatum through cholinergic interneuronsPreprint
Morgenstern, N. A., Isidro, A. F., Israely, I., & Costa, R. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.14.422716 · Cited by 2
Nicotinic Receptors and Mental Illness
Leonard, S. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1167-7_20 · Cited by 1
Animal Models of Parkinson’s Disease Induced by Toxins and Genetic Manipulation
Hisahara, S., & Shimoham, S. (2012) · InTech eBooks · doi:10.5772/19860 · Cited by 1
Metadata
- Authors
- Wonnacott, S., Kaiser, S., Mogg, A., Soliakov, L., & Jones, I. W.
- Affiliations
- University of Bath (GB)
- Corresponding author
- Wonnacott, Susan
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 393
- Issue
- 1-3
- Pages
- 51-58
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2023915778
- Cited by
- 232
- References
- 36
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 9 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 18 · 2017: 3 · 2016: 5 · 2015: 7 · 2014: 8 · 2013: 6 · 2012: 8
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Oxford
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- presynaptic nicotinic acetylcholine receptors, dopamine release, striatum, anatoxin-a, mecamylamine, synaptosomes, brain slices, glutamate release, glutamate receptor antagonists, dopaminergic terminals, immunogold electron microscopy, nicotinic receptor subtypes
- MeSH terms
- Animals, Corpus Striatum, Dopamine, Immunohistochemistry, Male, Receptors, Nicotinic, Synaptosomes, Tritium, Rats, Sprague-Dawley, Receptors, Presynaptic, Nicotinic Agonists, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review